Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 6, 2010, Pages 996-1006

  Luu, Ying ^a   Junker, Wade ^b   Rachagani, Satyanarayana ^b   Das, Srustidhar ^b   Batra, Surinder K ^b   Heinrikson, Robert L ^c   Shekels, Laurie L ^d   Ho, Samuel B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^c Proteos Inc   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cell migration; Epidermal growth factor; Inflammatory bowel disease; MUC17; Mucin

Indexed keywords

ACETIC ACID; DEXTRAN SULFATE; EPIDERMAL GROWTH FACTOR; ETOPOSIDE; MITOGEN ACTIVATED PROTEIN KINASE; MUCIN; PROTEIN MUC17; RECOMBINANT PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CARCINOGENICITY; CELL ADHESION; CELL AGGREGATION; CELL LINE; CELL MIGRATION; COLITIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENTERITIS; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; GENETIC TRANSFECTION; HEALING; HUMAN; HUMAN CELL; IN VIVO STUDY; INTESTINE CELL; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING;

ANIMALS; APOPTOSIS; CELL ADHESION; CELL AGGREGATION; CELL LINE, TUMOR; CELL PROLIFERATION; COLITIS; COLONIC NEOPLASMS; FEMALE; HUMANS; INTESTINAL MUCOSA; MICE; MICE, NUDE; MODELS, ANIMAL; MUCINS; NEOPLASM TRANSPLANTATION; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; WOUND HEALING;

MUS;

EID: 77953809261     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.03.001     Document Type: Article

References (48)

1. An G., Wei B., Xia B., McDaniel J.M., Ju T., Cummings R.D., et al. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med 2007, 204(6):1417-1429.
2. Argenzio R.A. Comparative pathophysiology of nonglandular ulcer disease: a review of experimental studies. Equine Vet J Suppl 1999, (29):19-23.
3. Borges H.L., Bird J., Wasson K., Cardiff R.D., Varki N., Eckmann L., et al. Tumor promotion by caspase-resistant retinoblastoma protein. Proc Natl Acad Sci USA 2005, 102(43):15587-15592.
4. Chaturvedi P., Singh A.P., Moniaux N., Senapati S., Chakraborty S., Meza J.L., et al. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Mol Cancer Res 2007, 5(4):309-320.
5. Cooper H.S., Murthy S.N., Shah R.S., Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993, 69(2):238-249.
6. Crawley S.C., Gum J.R., Hicks J.W., Pratt W.S., Aubert J.P., Swallow D.M., et al. Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin. Biochem Biophys Res Commun 1999, 263(3):728-736.
7. Dieckgraefe B.K., Weems D.M., Santoro S.A., Alpers D.H. ERK and p38 MAP kinase pathways are mediators of intestinal epithelial wound-induced signal transduction. Biochem Biophys Res Commun 1997, 233(2):389-394.
8. El-Assal O.N., Besner G.E. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastroenterology 2005, 129(2):609-625.
9. Fan G., Ma X., Kren B.T., Steer C.J. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene 1996, 12(9):1909-1919.
10. Feil W., Wenzl E., Vattay P., Starlinger M., Sogukoglu T., Schiessel R. Repair of rabbit duodenal mucosa after acid injury in vivo and in vitro. Gastroenterology 1987, 92(6):1973-1986.
11. Frey M.R., Golovin A., Polk D.B. Epidermal growth factor-stimulated intestinal epithelial cell migration requires Src family kinase-dependent p38 MAPK signaling. J Biol Chem 2004, 279(43):44513-44521.
12. Gibson P.R., Muir J.G. Reinforcing the mucus: a new therapeutic approach for ulcerative colitis?. Gut 2005, 54(7):900-903.
13. Graness A., Chwieralski C.E., Reinhold D., Thim L., Hoffmann W. Protein kinase C and ERK activation are required for TFF-peptide-stimulated bronchial epithelial cell migration and tumor necrosis factor-alpha-induced interleukin-6 (IL-6) and IL-8 secretion. J Biol Chem 2002, 277(21):18440-18446.
14. Greten F.R., Eckmann L., Greten T.F., Park J.M., Li Z.W., Egan L.J., et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004, 118(3):285-296.
15. Gum J.R., Ho J.J., Pratt W.S., Hicks J.W., Hill A.S., Vinall L.E., et al. MUC3 human intestinal mucin, analysis of gene structure, the carboxyl terminus, and a novel upstream repetitive region. J Biol Chem 1997, 272(42):26678-26686.
16. Hermiston M.L., Gordon J.I. In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J Cell Biol 1995, 129:489-506.
17. Ho S.B., Dvorak L.A., Moor R.E., Jacobson A.C., Frey M.R., Corredor J., et al. Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing. Gastroenterology 2006, 131(5):1501-1517.
18. Ho SB, Luu Y, Baskerville C, Shekels LL, Batra SK, Evans DB, et al. Activity of recombinant cysteine-rich domain proteins derived from the membrane-bound MUC17/Muc3 family mucins. Biochim Biophys Acta. 2010, (in press).
19. Hoffmann W. Trefoil factor family (TFF) peptides: regulators of mucosal regeneration and repair, and more. Peptides 2004, 25(5):727-730.
20. Kaiser G.C., Polk D.B. Tumor necrosis factor alpha regulates proliferation in a mouse intestinal cell line. Gastroenterology 1997, 112(4):1231-1240.
21. Kanai M., Mullen C., Podolsky D.K. Intestinal trefoil factor induces inactivation of extracellular signal-regulated protein kinase in intestinal epithelial cells. Proc Natl Acad Sci USA 1998, 95(1):178-182.
22. Karayiannakis A.J., Syrigos K.N., Efstathiou J., Valizadeh A., Noda M., Playford R.J., et al. Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease. J Pathol 1998, 185(4):413-418.
23. Kouniavsky G., Khaikin M., Zvibel I., Zippel D., Brill S., Halpern Z., et al. Stromal extracellular matrix reduces chemotherapy-induced apoptosis in colon cancer cell lines. Clin Exp Metastasis 2002, 19(1):55-60.
24. Kuan S.-F., Byrd J.C., Basbaum C.B., Kim Y.S. Characterization of quantitative mucin variants from a human colon cancer cell line. Cancer Res 1987, 47:5715-5724.
25. Magne N., Fischel J.L., Dubreuil A., Formento P., Poupon M.F., Laurent-Puig P., et al. Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 (" Iressa" ). Br J Cancer 2002, 86(9):1518-1523.
26. McAuley J.L., Linden S.K., Png C.W., King R.M., Pennington H.L., Gendler S.J., et al. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest 2007, 117(8):2313-2324.
27. McCafferty D.M., Mudgett J.S., Swain M.G., Kubes P. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 1997, 112(3):1022-1027.
28. McGuckin M.A., Eri R., Simms L.A., Florin T.H., Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2008.
29. Moniaux N., Junker W.M., Singh A.P., Jones A.M., Batra S.K. Characterization of human mucin MUC17, complete coding sequence and organization. J Biol Chem 2006, 281(33):23676-23685.
30. Murthy S.N., Cooper H.S., Shim H., Shah R.S., Ibrahim S.A., Sedergran D.J. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 1993, 38(9):1722-1734.
31. Nyati M.K., Maheshwari D., Hanasoge S., Sreekumar A., Rynkiewicz S.D., Chinnaiyan A.M., et al. Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo. Clin Cancer Res 2004, 10(2):691-700.
32. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990, 98(3):694-702.
33. Polk D.B. Shc is a substrate of the rat intestinal epidermal growth factor receptor tyrosine kinase. Gastroenterology 1995, 109(6):1845-1851.
34. Polk D.B. Epidermal growth factor receptor-stimulated intestinal epithelial cell migration requires phospholipase C activity. Gastroenterology 1998, 114(3):493-502.
35. Polk D.B., Tong W. Epidermal and hepatocyte growth factors stimulate chemotaxis in an intestinal epithelial cell line. Am J Physiol 1999, 277(6 Pt 1):C1149-C1159.
36. Quirk S.M., Porter D.A., Huber S.C., Cowan R.G. Potentiation of fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alfa and cycloheximide. Endocrinology 1998, 139:4860-4869.
37. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., et al. Cell migration: integrating signals from front to back. Science 2003, 302(5651):1704-1709.
38. Russo C.L., Spurr-Michaud S., Tisdale A., Pudney J., Anderson D., Gipson I.K. Mucin gene expression in human male urogenital tract epithelia. Hum Reprod 2006, 21(11):2783-2793.
39. Satoh Y., Saitoh D., Takeuchi A., Ojima K., Kouzu K., Kawakami S., et al. ERK2 dependent signaling contributes to wound healing after a partial-thickness burn. Biochem Biophys Res Commun 2009, 381(1):118-122.
40. Satsangi J., Parkes M., Louis E., Hashimoto L., Kato N., Welsh K., et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996, 14(2):199-202.
41. Shekels L.L., Hunninghake D.A., Tisdale A.S., Gipson I.K., Kieliszewsji M., Kozak C.A., et al. Cloning and characterization of mouse intestinal Muc3 mucin: 3' sequence contains epidermal-growth-factor-like domains. Biochem J 1998, 330:1301-1308.
42. Sinha A., Nightingale J., West K.P., Berlanga-Acosta J., Playford R.J. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med 2003, 349(4):350-357.
43. Stone E.L., Ismail M.N., Lee S.H., Luu Y., Ramirez K., Haslam S.M., et al. Glycosyltransferase function in core 2-type protein O glycosylation. Mol Cell Biol 2009, 29(13):3770-3782.
44. Tan C.T., Chu C.Y., Lu Y.C., Chang C.C., Lin B.R., Wu H.H., et al. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. Carcinogenesis 2008, 29(8):1519-1527.
45. Taupin D.R., Kinoshita K., Podolsky D.K. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci USA 2000, 97:799-804.
46. Tomita M., Itoh H., Ishikawa N., Higa A., Ide H., Murakumo Y., et al. Molecular cloning of mouse intestinal trefoil factor and its expression during goblet cell changes. Biochem J 1995, 311:293-297.
47. Van der Sluis M., De Koning B.A., De Bruijn A.C., Velcich A., Meijerink J.P., Van Goudoever J.B., et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006, 131(1):117-129.
48. Williams S.J., Munster D.J., Quin R.J., Gotley D.C., McGuckin M.A. The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. Biochem Biophys Res Commun 1999, 261:83-89.